<DOC>
	<DOCNO>NCT00598325</DOCNO>
	<brief_summary>Prior clinical trial examine several schedule nicotine vaccine ( NicVAX ) anti-nicotine antibody response , impact help smoker quit . The best schedule far one dose week 0 , 4 , 8 , 16 26 . This new study test whether change schedule week 0 , 4 , 8 , 12 16 improvement stimulate antibody nicotine . Routine vaccine safety information also collect . Amendment 1 add 6th dose week 26 , extend follow-up week 52 .</brief_summary>
	<brief_title>Antibody Safety Study 6 Doses NicVAX Smokers</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy smoker , ≥10 cigarettes per day 6 month , exhale carbon monoxide ≥10 ppm Written inform consent Negative urine pregnancy test , willing use birth control study , applicable Prior exposure nicotine vaccine Clinically significant allergic reaction , especially component vaccine Serious unstable clinical disease within past 6 month Use smoke cessation therapy within 30 day precede 1st dose Immunosuppression , due : steroid immunosuppressant last 30 day , history cancer cancer treatment last 60 month , know HIV infection , congenital acquire immunodeficiency Use vaccine influenza vaccine within 30 day prior study dose Use another IND drug device within 30 day precede 1st dose Inability follow protocol , illicit drug use past 12 month , psychiatric disorder past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Nicotine</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Tobacco</keyword>
	<keyword>Habits</keyword>
</DOC>